Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 06-Aug-24 5:00 PM View:  | Sullivan Lynne Marie CFO & Head of Corp. Dev. | Unity Biotechnology, Inc. (UBX) | 02-Aug-24 | Market Sale (Planned) | 139 | $1.53 | $212.67 | (< 1%) 56.2K to 56.06K | < 1% |
| 06-Aug-24 5:00 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 02-Aug-24 | Market Sale (Planned) | 604 | $1.53 | $924.12 | (< 1%) 76.93K to 76.33K | < 1% |
| 06-Aug-24 5:00 PM View: | Nguyen Alexander Hieu Chief Legal Officer | Unity Biotechnology, Inc. (UBX) | 02-Aug-24 | Market Sale (Planned) | 154 | $1.53 | $235.62 | (< 1%) 25.03K to 24.87K | < 1% |
| 26-Jun-24 4:05 PM View: | Nguyen Alexander Hieu Chief Legal Officer | Unity Biotechnology, Inc. (UBX) | 25-Jun-24 | Market Sale (Planned) | 78 | $1.40 | $109.20 | (< 1%) 25.1K to 25.03K | (9%) |
| 26-Jun-24 4:05 PM View: | Sullivan Lynne Marie CFO & Head of Corp. Dev. | Unity Biotechnology, Inc. (UBX) | 25-Jun-24 | Market Sale (Planned) | 324 | $1.40 | $453.60 | (< 1%) 33.01K to 32.69K | (9%) |
| 26-Jun-24 4:05 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 25-Jun-24 | Market Sale (Planned) | 1,214 | $1.40 | $1,699.60 | (2%) 78.14K to 76.93K | (9%) |
| 03-May-24 4:05 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 02-May-24 | Market Sale (Planned) | 603 | $1.55 | $934.65 | (< 1%) 78.75K to 78.14K | 2% |
| 27-Mar-24 4:10 PM View: | Nguyen Alexander Hieu Chief Legal Officer | Unity Biotechnology, Inc. (UBX) | 26-Mar-24 | Grant | 20,000 | -- | -- | 392% 5.1K to 25.1K | |
| 05-Feb-24 4:05 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 02-Feb-24 | Private Sale (Planned) | 680 | $1.71 | $1,162.80 | (< 1%) 79.43K to 78.75K | |
| 31-Jan-24 4:05 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 30-Jan-24 | Private Sale (Planned) | 1,183 | $1.71 | $2,022.93 | (1%) 80.61K to 79.43K | |
| 03-Nov-23 4:05 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 02-Nov-23 | Private Sale (Planned) | 589 | $1.83 | $1,077.87 | (< 1%) 81.2K to 80.61K | |
| 31-Oct-23 4:05 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 30-Oct-23 | Private Sale (Planned) | 1,024 | $1.90 | $1,945.60 | (1%) 82.22K to 81.2K | |
| 15-Sep-23 4:08 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 14-Sep-23 | Private Sale (Planned) | 1,246 | $2.47 | $3,077.62 | (1%) 83.47K to 82.22K | |
| 03-Aug-23 4:13 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 02-Aug-23 | Private Sale (Planned) | 581 | $2.94 | $1,708.14 | (< 1%) 84.05K to 83.47K | |
| 01-Aug-23 4:05 PM View: | Ghosh Anirvan Chief Executive Officer | Unity Biotechnology, Inc. (UBX) | 31-Jul-23 | Private Sale (Planned) | 1,020 | $2.86 | $2,917.20 | (1%) 85.07K to 84.05K | |
| 27-Jun-23 5:10 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 26-Jun-23 | Private Sale (Planned) | 1,177 | $3.20 | $3,766.40 | (1%) 86.25K to 85.07K | |
| 15-Jun-23 5:58 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 14-Jun-23 | Private Sale (Planned) | 1,212 | $3.39 | $4,108.68 | (1%) 87.46K to 86.25K | |
| 03-May-23 5:26 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 02-May-23 | Private Sale (Planned) | 588 | $2.17 | $1,275.96 | (< 1%) 88.05K to 87.46K | |
| 02-May-23 10:00 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 01-May-23 | Private Sale (Planned) | 1,020 | $2.15 | $2,193.00 | (92%) 1.11K to 88 | |
| 03-Apr-23 4:51 PM View: | Dananberg Jamie Chief Medical Officer | Unity Biotechnology, Inc. (UBX) | 31-Mar-23 | Private Sale (Planned) | 420 | $1.70 | $714.00 | (< 1%) 63.24K to 62.82K | |
| 03-Apr-23 4:55 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 31-Mar-23 | Private Sale (Planned) | 1,959 | $1.70 | $3,330.30 | (2%) 91.03K to 89.07K | |
| 15-Mar-23 4:51 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 14-Mar-23 | Private Sale (Planned) | 1,210 | $4.00 | $4,840.00 | (1%) 92.23K to 91.03K | |
| 15-Mar-23 5:02 PM View: | Dananberg Jamie Chief Medical Officer | Unity Biotechnology, Inc. (UBX) | 14-Mar-23 | Private Sale (Planned) | 1,005 | $4.00 | $4,020.00 | (2%) 64.24K to 63.24K | |
| 03-Feb-23 4:33 PM View: | Dananberg Jamie Chief Medical Officer | Unity Biotechnology, Inc. (UBX) | 02-Feb-23 | Private Sale (Planned) | 863 | $4.84 | $4,176.92 | (1%) 65.11K to 64.24K | |
| 03-Feb-23 4:27 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 02-Feb-23 | Private Sale (Planned) | 2,573 | $4.84 | $12,453.30 | (3%) 94.81K to 92.23K | |
| 31-Jan-23 4:48 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 30-Jan-23 | Private Sale (Planned) | 1,140 | $4.45 | $5,073.00 | (1%) 95.95K to 94.81K | |
| 15-Dec-22 4:48 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 14-Dec-22 | Private Sale (Planned) | 1,274 | $2.85 | $3,630.90 | (1%) 97.22K to 95.95K | |
| 15-Dec-22 4:44 PM View: | Dananberg Jamie Chief Medical Officer | Unity Biotechnology, Inc. (UBX) | 14-Dec-22 | Private Sale (Planned) | 1,016 | $2.85 | $2,895.60 | (2%) 66.12K to 65.11K | |
| 04-Nov-22 4:49 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 03-Nov-22 | Private Sale (Planned) | 1,099 | $2.40 | $2,637.60 | (1%) 98.32K to 97.22K | |
| 15-Sep-22 4:11 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 14-Sep-22 | Sale (Planned) | 13,706 | $0.48 | $6,578.88 | (1%) 996.92K to 983.21K | |
| 15-Sep-22 4:10 PM View: | Dananberg Jamie Chief Medical Officer | Unity Biotechnology, Inc. (UBX) | 14-Sep-22 | Sale (Planned) | 10,923 | $0.48 | $5,243.04 | (2%) 672.14K to 661.21K | |
| 02-Aug-22 4:12 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 01-Aug-22 | Sale (Planned) | 10,446 | $0.67 | $6,998.82 | (1%) 1.01M to 996.92K | |
| 28-Jun-22 6:11 PM View: | Dananberg Jamie Chief Medical Officer | Unity Biotechnology, Inc. (UBX) | 27-Jun-22 | Sale (Planned) | 4,398 | $0.59 | $2,594.82 | (< 1%) 676.53K to 672.14K | |
| 28-Jun-22 6:07 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 27-Jun-22 | Sale (Planned) | 12,149 | $0.59 | $7,167.91 | (1%) 1.02M to 1.01M | |
| 22-Jun-22 4:49 PM View: | Dananberg Jamie Chief Medical Officer | Unity Biotechnology, Inc. (UBX) | 21-Jun-22 | Sale (Planned) | 3,697 | $0.62 | $2,292.14 | (< 1%) 680.23K to 676.53K | |
| 15-Jun-22 4:36 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 14-Jun-22 | Payment of Exercise | 12,683 | $0.63 | $7,990.29 | (1%) 1.03M to 1.02M | |
| 15-Jun-22 4:34 PM View: | Dananberg Jamie Chief Medical Officer | Unity Biotechnology, Inc. (UBX) | 14-Jun-22 | Payment of Exercise | 10,530 | $0.63 | $6,633.90 | (2%) 690.76K to 680.23K | |
| 21-Nov-22 5:26 PM View: | Sullivan Lynne Marie CFO & Head of Corp. Dev. | Unity Biotechnology, Inc. (UBX) | 15-May-22 | Acquisition (other) | 925 | $6.89 | $6,373.25 | 3% 32.08K to 33.01K | |
| 03-May-22 5:18 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 02-May-22 | Payment of Exercise | 7,729 | $0.88 | $6,801.52 | (< 1%) 1.04M to 1.03M | |
| 01-Apr-22 4:24 PM View: | Dananberg Jamie Chief Medical Officer | Unity Biotechnology, Inc. (UBX) | 31-Mar-22 | Payment of Exercise | 4,188 | $1.14 | $4,774.32 | (< 1%) 694.95K to 690.76K | |
| 01-Apr-22 4:24 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 31-Mar-22 | Payment of Exercise | 14,472 | $1.14 | $16,498.10 | (1%) 1.05M to 1.04M | |
| 15-Mar-22 4:53 PM View: | Dananberg Jamie Chief Medical Officer | Unity Biotechnology, Inc. (UBX) | 14-Mar-22 | Payment of Exercise | 10,581 | $0.88 | $9,311.28 | (1%) 705.53K to 694.95K | |
| 15-Mar-22 4:54 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 14-Mar-22 | Payment of Exercise | 9,272 | $0.88 | $8,159.36 | (< 1%) 1.06M to 1.05M | |
| 15-Feb-22 5:17 PM View: | Sullivan Lynne Marie CFO & Head of Corp. Dev. | Unity Biotechnology, Inc. (UBX) | 09-Feb-22 | Grant | 50,000 | -- | -- | 18% 276.79K to 326.79K | |
| 15-Feb-22 5:23 PM View: | Dananberg Jamie Chief Medical Officer | Unity Biotechnology, Inc. (UBX) | 09-Feb-22 | Grant | 45,833 | -- | -- | 7% 659.7K to 705.53K | |
| 15-Feb-22 5:21 PM View: | Nguyen Alexander Hieu See Remarks | Unity Biotechnology, Inc. (UBX) | 09-Feb-22 | Grant | 45,833 | -- | -- | 880% 5.21K to 51.04K | |
| 15-Feb-22 5:12 PM View: | Ghosh Anirvan Chief Executive Officer Director | Unity Biotechnology, Inc. (UBX) | 09-Feb-22 | Grant | 141,667 | -- | -- | 15% 922.0K to 1.06M | |
| 15-Dec-21 4:26 PM View: | Dananberg Jamie Chief Medical Officer | Unity Biotechnology, Inc. (UBX) | 14-Dec-21 | Payment of Exercise | 10,614 | $1.63 | $17,300.80 | (2%) 670.31K to 659.7K | 3% |
| 28-Jun-21 5:17 PM View: | Sullivan Lynne Marie CFO & Head of Corp. Dev. | Unity Biotechnology, Inc. (UBX) | 24-Jun-21 | Grant | 30,833 | -- | -- | 13% 240.0K to 270.83K | |
| 28-Jun-21 5:16 PM View: | Dananberg Jamie Chief Medical Officer | Unity Biotechnology, Inc. (UBX) | 24-Jun-21 | Grant | 25,000 | -- | -- | 4% 685.88K to 710.88K |
